Literature DB >> 6742818

Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria.

K Vosbeck, P R James, W Zimmermann.   

Abstract

Antibiotics such as rifampin that act on phagocytosed bacteria have clinical advantages. The investigation of such intraphagocytic activity of antibiotics is, however, hampered by the time-consuming and cumbersome procedures necessary for enumerating viable bacteria. We have developed a semiautomatic biophotometric method for this purpose that permits the processing of relatively large numbers of samples. Using this method with Staphyloccus aureus Wood 46 as a test organism, we studied the dose dependence of the activities of a number of antibiotics against intraphagocytic bacteria. We could confirm the very good intracellular activity of rifampin. Its activity at low concentrations was slightly better against intracellular than against extracellular bacteria. In contrast, clindamycin and erythromycin, both of which have been reported to accumulate within phagocytes, did not exhibit a correspondingly enhanced intracellular activity, erythromycin being active intracellularly only at high concentrations. Clindamycin and vancomycin were effective against intracellular organisms, but only at relatively high concentrations owing to their low bactericidal activity against S. aureus Wood 46. Penicillin G, ampicillin, gentamicin, and streptomycin exhibited no useful intracellular activity. These results demonstrate that radioactive accumulation studies of antibacterial agents are not sufficient to show intracellular activity. Intracellular activity must be demonstrated in a functional test, preferably with graded concentrations of the test substance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742818      PMCID: PMC185632          DOI: 10.1128/AAC.25.6.735

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

2.  Phagocyte strategy vs. microbial tactics.

Authors:  P Densen; G L Mandell
Journal:  Rev Infect Dis       Date:  1980 Sep-Oct

3.  Protection of phagocytized bacteria from the killing action of antibiotics.

Authors:  B Holmes; P G Quie; D B Windhorst; B Pollara; R A Good
Journal:  Nature       Date:  1966-06-11       Impact factor: 49.962

4.  The effects of cloxacillin on staphylococci phagocytosed by bovine neutrophils.

Authors:  N Craven; J C Anderson
Journal:  Res Vet Sci       Date:  1980-07       Impact factor: 2.534

5.  Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes.

Authors:  P Vaudaux; F A Waldvogel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

6.  In vitro efficacy of several antibiotics against intracellular S. aureus in chronic granulomatous disease.

Authors:  W Zimmerli; P D Lew; S Suter; M Wyss; F A Waldvogel
Journal:  Helv Paediatr Acta       Date:  1983-03

7.  Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

8.  Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.

Authors:  J M Dickinson; D A Mitchison
Journal:  Am Rev Respir Dis       Date:  1981-04

9.  The survival of staphylococci within human leukocytes.

Authors:  D E ROGERS; R TOMPSETT
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

10.  Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte.

Authors:  M S Jensen; D F Bainton
Journal:  J Cell Biol       Date:  1973-02       Impact factor: 10.539

View more
  13 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

Review 2.  Activity of antibiotics against microorganisms ingested by mononuclear phagocytes.

Authors:  P J van den Broek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

3.  Intracellular bactericidal activity of fosfomycin against staphylococci: a comparison with other antibiotics.

Authors:  M Trautmann; C Meincke; K Vogt; M Ruhnke; A M Lajous-Petter
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

4.  Penetration of brodimoprim into human neutrophils and intracellular activity.

Authors:  P C Braga; M Dal Sasso; S Maci; G Bondiolotti; E Fonti; S Reggio
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 5.  Intracellular concentrations of antibacterial agents and related clinical implications.

Authors:  J D Butts
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

6.  Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay.

Authors:  M U Shiloh; J Ruan; C Nathan
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes.

Authors:  P H Höger; K Vosbeck; R Seger; W H Hitzig
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

8.  Reduction of wall degradability of clindamycin-treated staphylococci within macrophages.

Authors:  J Wecke; L Johannsen; P Giesbrecht
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 9.  Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils.

Authors:  R J Yancey; M S Sanchez; C W Ford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

10.  Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes.

Authors:  A Pascual; D Tsukayama; J Kovarik; G Gekker; P Peterson
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.